Publications by authors named "M Vitezic"

The genetic architecture of antidepressant response is poorly understood. Polygenic risk scores (PRS), exploration of placebo response and the use of sub-scales might provide insights. Here, we investigate the association between PRSs for relevant complex traits and response to vortioxetine treatment and placebo using clinical scales, including sub-scales and self-reported assessments.

View Article and Find Full Text PDF

There has recently been marked progress in identifying genetic risk factors for major depression (MD) and bipolar disorder (BD); however, few systematic efforts have been made to elucidate heterogeneity that exists within and across these diagnostic taxa. The Affective disorders, Environment, and Cognitive Trait (AFFECT) study presents an opportunity to identify and associate the structure of cognition and symptom-level domains across the mood disorder spectrum in a prospective study from a diverse US population.Participants were recruited from the 23andMe, Inc research participant database and through social media; self-reported diagnosis of MD or BD by a medical professional and medication status data were used to enrich for mood-disorder cases.

View Article and Find Full Text PDF

A better understanding of the biological factors underlying antidepressant treatment in patients with major depressive disorder (MDD) is needed. We perform gene expression analyses and explore sources of variability in peripheral blood related to antidepressant treatment and treatment response in patients suffering from recurrent MDD at baseline and after 8 weeks of treatment. The study includes 281 patients, which were randomized to 8 weeks of treatment with vortioxetine (N = 184) or placebo (N = 97).

View Article and Find Full Text PDF
Article Synopsis
  • Inflammatory bowel disease (IBD) includes Crohn's disease and ulcerative colitis, but its molecular causes are not well understood, especially since many associated genetic variations are found in non-coding regions.
  • Researchers studied transcription start sites (TSSs) and enhancers in the colon of 94 IBD patients and controls, discovering that IBD-related genetic variations are closely linked to specific gene regulation patterns.
  • With findings indicating that only 35 TSSs can differentiate between active Crohn's disease, ulcerative colitis, and controls with 85% accuracy, this research lays the groundwork for better understanding the genetics and molecular mechanisms of IBD.
View Article and Find Full Text PDF

Background: Evolutionarily conserved RFX transcription factors (TFs) regulate their target genes through a DNA sequence motif called the X-box. Thereby they regulate cellular specialization and terminal differentiation. Here, we provide a comprehensive analysis of all the eight human RFX genes (RFX1-8), their spatial and temporal expression profiles, potential upstream regulators and target genes.

View Article and Find Full Text PDF